Healthy volunteers inhale flu virus to help scientists fight future outbreaks
NCT ID NCT06753474
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study gives healthy adults aged 18-49 a controlled dose of the H3N2 flu virus via nasal spray to observe how the immune system fights it and how the virus spreads. Participants stay in the hospital for 8-12 days for close monitoring, with follow-up visits over 5 months. The goal is to gather knowledge to develop better flu vaccines and drugs.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Emory University Hospital Clinical Research Network
RECRUITINGAtlanta, Georgia, 30322, United States
-
Hope Clinic
RECRUITINGAtlanta, Georgia, 30322, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Flu vaccine showdown: which shot protects seniors best?
- Can a simple breath test catch flu in High-HIV regions?
- Can a simple mask stop the flu? 2,000 volunteers put it to the test
- Can a stronger flu shot better protect seniors?
- Flu shot showdown: Cell-Grown vs recombinant vaccine put to the test
- New mRNA vaccine aims to outsmart flu by targeting its hidden parts